hydralazine hydrochloride

Generic: hydralazine hydrochloride

Labeler: a-s medication solutions
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name hydralazine hydrochloride
Generic Name hydralazine hydrochloride
Labeler a-s medication solutions
Dosage Form TABLET
Routes
ORAL
Active Ingredients

hydralazine hydrochloride 50 mg/1

Manufacturer
A-S Medication Solutions

Identifiers & Regulatory

Product NDC 50090-7210
Product ID 50090-7210_ee93239a-2a97-45d7-aeb8-a705343820dd
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA205236
Listing Expiration 2026-12-31
Marketing Start 2017-05-26

Pharmacologic Class

Classes
arteriolar vasodilation [pe] arteriolar vasodilator [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 500907210
Hyphenated Format 50090-7210

Supplemental Identifiers

RxCUI
905395
UNII
FD171B778Y

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name hydralazine hydrochloride (source: ndc)
Generic Name hydralazine hydrochloride (source: ndc)
Application Number ANDA205236 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 50 mg/1
source: ndc
Packaging
  • 60 TABLET in 1 BOTTLE (50090-7210-1)
  • 180 TABLET in 1 BOTTLE (50090-7210-2)
  • 90 TABLET in 1 BOTTLE (50090-7210-3)
  • 270 TABLET in 1 BOTTLE (50090-7210-4)
source: ndc

Packages (4)

Ingredients (1)

hydralazine hydrochloride (50 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "ee93239a-2a97-45d7-aeb8-a705343820dd", "openfda": {"unii": ["FD171B778Y"], "rxcui": ["905395"], "spl_set_id": ["a8194ac4-02d5-4aa1-b4e4-a3759f6f64b5"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (50090-7210-1)", "package_ndc": "50090-7210-1", "marketing_start_date": "20240805"}, {"sample": false, "description": "180 TABLET in 1 BOTTLE (50090-7210-2)", "package_ndc": "50090-7210-2", "marketing_start_date": "20240805"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (50090-7210-3)", "package_ndc": "50090-7210-3", "marketing_start_date": "20240805"}, {"sample": false, "description": "270 TABLET in 1 BOTTLE (50090-7210-4)", "package_ndc": "50090-7210-4", "marketing_start_date": "20240805"}], "brand_name": "Hydralazine Hydrochloride", "product_id": "50090-7210_ee93239a-2a97-45d7-aeb8-a705343820dd", "dosage_form": "TABLET", "pharm_class": ["Arteriolar Vasodilation [PE]", "Arteriolar Vasodilator [EPC]"], "product_ndc": "50090-7210", "generic_name": "Hydralazine Hydrochloride", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Hydralazine Hydrochloride", "active_ingredients": [{"name": "HYDRALAZINE HYDROCHLORIDE", "strength": "50 mg/1"}], "application_number": "ANDA205236", "marketing_category": "ANDA", "marketing_start_date": "20170526", "listing_expiration_date": "20261231"}